We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Information for pregnant women to understand what it means to be a haemoglobin O Arab carrier.
This guidance relates to the legal criteria for determining whether a building is considered a higher-risk building under the Building Safety Act 2022 and the Higher-Risk Buildings (Descriptions and Supplementary Provisions) Regulations 2023. It relates to the definition of higher-risk...
Information for pregnant women who are offered a chorionic villus sampling (CVS) or amniocentesis diagnostic test.
Provides an overview of PFM v10a, including the forecasting and appraisal methodology involved and the tool's unique features.
Information for pregnant women to understand what it means to be a sickle cell carrier.
Role description and qualification specification for early years special educational needs coordinators (SENCOs).
Information for pregnant women to understand what it means to be a delta beta thalassaemia.
Information for parents to explain what it means to have a positive screening result for carrying the cystic fibrosis (CF) gene.
Information to help healthcare professionals speak with parents at risk of having a child with sickle cell disease.
Consultation on proposed Higher Risk Buildings (Descriptions and Supplementary Provisions) Regulations which complete the definition of higher-risk building for the new building safety regime.
Information for pregnant women to understand what it means to be a haemoglobin C carrier.
Bristol-Myers Squibb Pharmaceuticals Limited has informed the MHRA that a potential product quality issue has been detected, relating to incomplete crimping of the metal crimp cap of OPDIVO 10mg/mL concentrate for solution for infusion (nivolumab) (1VLX10ML).
A list of the programmes produced by the PSBs outside of the M25, and criteria against which each programme qualifies as Made Outside London
These documents set out the reasons for repeat blood tests in newborn blood spot (NBS) screening.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.